Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Goodfellow Gems #55
Goodfellow Gems #55
Wednesday 10 May 2017, 02:53 PM
Beta-blockers no longer first line for simple hypertension
Initiating treatment of hypertension with beta-blockers leads to modest CVD reductions and little or no effects on mortality (atenolol mainly studied)
References
1. Wiysonge CS, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002003.pub5/abstract;jsessionid=34B9346C6964ECB39CF395D4C5441945.f04t03
2. New Zealand Primary Care handbook 2012, p37 \http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012
3. Medsafe Datasheet 2014. http://www.medsafe.govt.nz/profs/Datasheet/b/bosvatetab.pdf